Literature DB >> 17587565

Ageing and dexamethasone associated sarcopenia: peculiarities of regeneration.

Priit Kaasik1, Maria Umnova, Ando Pehme, Karin Alev, Maire Aru, Anne Selart, Teet Seene.   

Abstract

The purpose of this study was to assess the development of ageing- and glucocorticoid-related sarcopenia on the level of myofibrillar apparatus, paying attention to the synthesis (SR) and degradation rate (DR) of contractile proteins, muscle strength, and daily motor activity. We also wanted to test the effect of ageing and dexamethasone (Dex) excess on the regeneration peculiarities of skeletal muscle autografts. Four and 30-month-old male rats of the Wistar strain were used. Ageing associated sarcopenia was calculated from gastrocnemius muscle relative mass decrease (from 5.6 +/- 0.08 to 3.35 +/- 0.04; p < 0.001). The SR of MyHC in old rats was approximately 30% and actin approximately 23% lower than in young rats. Dex treatment decreased SR of two main contractile proteins significantly in both age groups (p < 0.001) and increased DR during ageing from 2.11 +/- 0.15 to 4.09 +/- 0.29%/day (p < 0.001). Hindlimb grip strength in young rats was 5.90 +/- 0.35 N/100 g bw and 2.64 +/- 0.2 N/100 g bw (p < 0.001) in old rats. Autografts of old rats have a higher content of adipose tissue 14.9 +/- 1.1% in comparison with young rats 6.8 +/- 0.51% (p < 0.001) and less muscle tissue 39.8 +/- 2.6% and 48.3 +/- 2.8%, respectively (p < 0.05). Both, ageing and dex-caused sarcopenic muscles have diminished capacity for regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587565     DOI: 10.1016/j.jsbmb.2006.11.024

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  13 in total

1.  The isolated muscle fibre as a model of disuse atrophy: characterization using PhAct, a method to quantify f-actin.

Authors:  William J Duddy; Tatiana Cohen; Stephanie Duguez; Terence A Partridge
Journal:  Exp Cell Res       Date:  2011-05-20       Impact factor: 3.905

2.  Voluntary exercise improves metabolic profile in high-fat fed glucocorticoid-treated rats.

Authors:  Jacqueline L Beaudry; Emily C Dunford; Erwan Leclair; Erin R Mandel; Ashley J Peckett; Tara L Haas; Michael C Riddell
Journal:  J Appl Physiol (1985)       Date:  2015-03-19

3.  Beneficial Effect of H2S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin.

Authors:  Laura Micheli; Emma Mitidieri; Carlotta Turnaturi; Domenico Vanacore; Clara Ciampi; Elena Lucarini; Giuseppe Cirino; Carla Ghelardini; Raffaella Sorrentino; Lorenzo Di Cesare Mannelli; Roberta d'Emmanuele di Villa Bianca
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

4.  Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment.

Authors:  Matheus Barel; Otávio André Brogin Perez; Vanessa Aparecida Giozzet; Alex Rafacho; José Roberto Bosqueiro; Sandra Lia do Amaral
Journal:  Eur J Appl Physiol       Date:  2009-12-06       Impact factor: 3.078

5.  Role of exercise therapy in prevention of decline in aging muscle function: glucocorticoid myopathy and unloading.

Authors:  Teet Seene; Priit Kaasik
Journal:  J Aging Res       Date:  2012-06-17

6.  β-Hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle.

Authors:  María D Girón; Jose D Vílchez; Sathyavageeswaran Shreeram; Rafael Salto; Manuel Manzano; Elena Cabrera; Nefertiti Campos; Neile K Edens; Ricardo Rueda; Jose M López-Pedrosa
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 7.  MicroRNA-Regulated Proinflammatory Cytokines in Sarcopenia.

Authors:  Jingjing Fan; Xianjuan Kou; Yi Yang; Ning Chen
Journal:  Mediators Inflamm       Date:  2016-06-13       Impact factor: 4.711

Review 8.  Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy.

Authors:  Sakulrat Mankhong; Sujin Kim; Sohee Moon; Hyo-Bum Kwak; Dong-Ho Park; Ju-Hee Kang
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

9.  Hydrogen Sulfide Donor NaHS Improves Metabolism and Reduces Muscle Atrophy in Type 2 Diabetes: Implication for Understanding Sarcopenic Pathophysiology.

Authors:  Milad S Bitar; Joelle Nader; Waleed Al-Ali; Ashraf Al Madhoun; Hossein Arefanian; Fahd Al-Mulla
Journal:  Oxid Med Cell Longev       Date:  2018-10-30       Impact factor: 6.543

Review 10.  Role of Myofibrillar Protein Catabolism in Development of Glucocorticoid Myopathy: Aging and Functional Activity Aspects.

Authors:  Teet Seene; Priit Kaasik
Journal:  Metabolites       Date:  2016-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.